Characteristics of participants completing the first Delphi round
| Characteristic | Number (%) |
|---|---|
| General characteristics (total panel) | n=91 |
| Gender | |
| Women | 49 (54) |
| Age | |
| Median (IQR) | 51 (40–58) |
| Highest education | |
| Postgraduate degree (MSc, PhD) | 56 (62) |
| Graduated from college/university | 18 (20) |
| Graduated from high school | 10 (11) |
| Graduated from primary school | 1 (1) |
| Other | 6 (7) |
| Stakeholder group | |
| Clinician | 19 (21) |
| Researcher | 13 (14) |
| Professional working as clinician and researcher | 18 (20) |
| Patient | 41 (45) |
| Clinician/researcher characteristics | n=50 |
| Country of work | |
| UK | 11 (22) |
| The Netherlands | 8 (16) |
| Australia | 7 (14) |
| USA | 7 (14) |
| Canada | 6 (12) |
| Sweden | 2 (4) |
| Ireland | 2 (4) |
| Turkey | 2 (4) |
| Other (Brazil, Finland, Germany, Italy, Norway) | 5 (10) |
| Field of work | |
| Orthopaedics | 17 (34) |
| Physiotherapy | 15 (30) |
| Rheumatology | 5 (10) |
| Epidemiology | 4 (8) |
| General practice/family medicine | 3 (6) |
| Other (emergency medicine, physical medicine and rehabilitation) | 6 (12) |
| Research experience | |
| Conducted at least one clinical trial for a shoulder disorder | 40 (80) |
| Conducted at least one systematic review for a shoulder disorder | 23 (46) |
| Developed or tested a measurement instrument for a shoulder disorder | 15 (30) |
| Participated in development of other COSs | 20 (40) |
| Patient characteristics | n=41 |
| Country of residence | |
| USA | 18 (44) |
| UK | 6 (15) |
| The Netherlands | 4 (10) |
| Austria | 3 (7) |
| Australia | 2 (5) |
| Germany | 2 (5) |
| Other (Belgium, Canada, Poland, Slovakia) | 4 (10) |
| Shoulder disorder history | |
| Have sought healthcare for a shoulder disorder at least once | 36 (88) |
| Currently have a shoulder disorder | 27 (66) |
| Duration of current shoulder disorder | |
| Less than 6 weeks | 2 (7)* |
| Between 6 and 12 weeks | 3 (11)* |
| More than 3 months | 15 (56)* |
| Not stated | 7 (26)* |
*Denominator is the number of patients who currently have a shoulder disorder (n=27).